Deliver Your News to the World

CybeRelease: (OTC PK: APPI) CTO Interviewed by


( CybeRelease, April 11, 2007 ) - Lake Harmony, PA - Mr. Edwin Zhao, Chief Technology Officer of APPI/World Health Energy (OTC BB: APPI), updated the investment community on the company’s progress with it biodiesel business plan in an exclusive interview with Topics discussed included the pending financing for two biodiesel plants, tax incentives to alternative energy producers and the company’s intent to utilize a unique process for biodiesel production. In addition, Mr. Zhao divulged the company’s long-term plan to enter the ethanol market.

To hear the interview in its entirety, visit, and click on “Interviews.” The interview can be accessed either by locating the company’s ticker symbol under the appropriate exchange on the left-hand column of the “Interviews” section of the site, or by entering the company’s ticker symbol in the Search Archive window.

To receive company press releases and industry updates, investors should please send an e-mail to

About World Health Energy, Inc.

World Health Energy, Inc. is a renewable energy company focused on developing and producing alternative fuels. The company plans to use renewable, cost-effective agricultural products domestically and internationally to develop natural alternative fuels.

About Advanced Plant Pharmaceuticals, Inc. (

Advanced Plant Pharmaceuticals, Inc.has focused on the research and development of whole plant-based nutritionals and has recently announced a shift in focus in its business plan to the production of environmentally friendly, alternative fuel production.

To read the complete release, go to

For a Free News letter, go to

CybeRelease Gainers are Comcast Corporation (Nasdaq: CMCSA), Charter Communications, Inc. (Nasdaq: CHTR), Finisar Corporation (Nasdaq: FNSR), Tractor Supply Company (Nasdaq: TSCO), Akamai Technologies, Inc. (Nasdaq: AKAM), DayStar Technologies, Inc. (Nasdaq: DSTI), Hoku Scientific, Inc. (Nasdaq: HOKU) and Amarin Corporation PLC (Nasdaq: AMRN).

CybeRelease Decliners are American Medical Systems Holdings, Inc. (Nasdaq: AMMD), CheckFree Corporation (Nasdaq: CKFR), BioLase Technology, Inc. (Nasdaq: BLTI), Neurochem Inc. (Nasdaq: NRMX), Focus Media Holding Limited (Nasdaq: FMCN), Antigenics Inc. (Nasdaq: AGEN), Shuffle Master, Inc. (Nasdaq: SHFL) and Targeted Genetics Corporation (Nasdaq: TGEN).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for informational purposes only and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.